Structure Therapeutics Inc.

Healthcare · Biotechnology · United States

Last price 21.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.56B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671 and ACCG-3535, an oral small molecule amylin receptor agonist that...